Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexaria Bioscience (LEXX) Other financing activities (2022)

Historic Other financing activities for Lexaria Bioscience (LEXX) over the last 4 years, with Q2 2022 value amounting to -$300000.0.

  • Lexaria Bioscience's Other financing activities changed N/A to -$300000.0 in Q2 2022 from the same period last year, while for Oct 2011 it was $7.1 million, marking a year-over-year increase of 1718.71%. This contributed to the annual value of $1.0 million for FY2019, which is N/A changed from last year.
  • As of Q2 2022, Lexaria Bioscience's Other financing activities stood at -$300000.0.
  • Lexaria Bioscience's 5-year Other financing activities high stood at $1.2 million for Q1 2022, and its period low was -$300000.0 during Q2 2022.